New pill tested to fight dangerous fatty liver disease
NCT ID NCT06168383
Summary
This study tested whether a new oral drug called HSK31679 could improve liver health in people with NASH, a serious form of fatty liver disease that causes scarring. About 186 Chinese adults with confirmed NASH and moderate liver scarring took either the drug or a placebo pill daily for one year. Researchers measured if the drug reduced liver fat and inflammation while preventing further scarring.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for NON-ALCOHOLIC STEATOHEPATITIS (NASH) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Beijing Tsinghua Changgung Hospital, Tsinghua University
Beijing, China
Conditions
Explore the condition pages connected to this study.